Skip to main content

$1.17 (0%)

High

$1.20

Low

$1.17

Trades

19

Turnover

$42,881

Volume

36,527
30 June 2023 at 4:10pm
Register to track EMV and receive email alerts.
Subject
EMV Ann: Breakthroughs in Technology & Product Development

EMV Ann: Recruitment at Royal Melbourne Hospital Commences

EMV Ann: $1.75M Manufacturing Grant Payment Received

EMV Ann: Leadership Transition

EMV Ann: Stage 2 of Clinical Trial Activated

EMV Ann: Change of Director's Interest Notice

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: Notification regarding unquoted securities - EMV

EMV Ann: Product Development Milestones & Grant Funding Achieved

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: Clinical Advisory Board Appointment

EMV Ann: CEO Half-Year Update

EMV Ann: Half Yearly Report and Accounts

EMV Ann: Clinical Trial Stage 1 Enrolment Completed

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: Trial Progressing on Target and ASA Milestone Achieved

EMV Ann: Change of Director's Interest Notice X 6

EMV Ann: Notification regarding unquoted securities - EMV

EMV Ann: $8.8m In Non-Dilutive Funding To Be Received This Quarter

EMV Ann: EMVision Commences Clinical Trial

EMV Ann: Results of Annual General Meeting

EMV Ann: AGM Chairman Address and Presentation

EMV Ann: Portable Brain Scanner Delivered to First Clinical Site

EMV Ann: EMVision Backed By NSW Medical Devices Fund With $2.5m Grant

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: $5m Modern Manufacturing Initiative Funding Agreement Signed

EMV Ann: Notice of Annual General Meeting/Proxy Form

EMV Ann: Ethics Approval Received For Multi-Centre Clinical Trial

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: Notification regarding unquoted securities - EMV

EMV Ann: Employee Incentive Plan Issue

EMV Ann: Date of AGM and Closing Date for Director Nominations

EMV Ann: Investor Presentation - E&P Healthcare Conference

EMV Ann: Appendix 4G & Corporate Governance Statement

EMV Ann: Appendix 4E & Annual Report to 30 June 2022

EMV Ann: $5m Modern Manufacturing Initiative Grant Proceeding

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: Centres of Excellence Confirmed as First Two Clinical Sites

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: EMVision Achieves First Responder Milestone

EMV Ann: EMVision Awarded $5m Non-Dilutive Funding via MMI Grant

EMV Ann: Trading Halt

EMV Ann: Pause in Trading

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

Register to track EMV and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
IBX
IPD
MX1
RSH
SOM